Community screening of participants across community pharmacies detecting asymptomatic clinical markers or risk factors associated with cardiovascular disease and chronic disease.

A Comprehensive risk assessment will be performed by a trained pharmacist in the community pharmacy setting. Collection of your age, gender, smoking status, blood pressure measurement and heart rate and questions from the Australian type 2 diabetes risk assessment tool (AUSDRISK) be taken. A waist measurement and a finger prick blood test that measures blood sugar and cholesterol. The Complete time of this test would be 20-30 minutes.. Blood pressure measurement and heart rate will be measured using an omron BP machine and the finger prick blood sample will be analysed through the cobas machine with an immediate result printed. There will be the requirement to complete some validate questionnaires as part of this visit, (Ausrisk, 36 item health survey questionnaire, Health care utilisation questionnaire). Face to face contact at the pharmacy site (with a trained pharmacist performing the assessment/visit) will be required at baseline, 6 month visit and 12 month vist. A total of 3 visits for the duration of 12 month long trial will be required for consented participants. On site monitoring and source verification checks will be performed on case report forms during the 12 month trial. SMS reminders will be sent to consented participants to advise when their 6 month or 12 month visit is due. A internal database will monitor participant visit schedules to check for adherence to the protocol and documentation of any minor deviations from this for example on holiday or missed visits.